Prime Capital Investment Advisors’s Idexx Laboratories IDXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.08M Buy
3,952
+47
+1% +$26.4K 0.02% 374
2026
Q1
$2.19M Sell
3,905
-18
-0.5% -$11.5K 0.03% 347
2025
Q4
$2.65M Buy
3,923
+18
+0.5% +$12.3K 0.03% 304
2025
Q3
$2.49M Sell
3,905
-7
-0.2% -$4.25K 0.03% 306
2025
Q2
$2.1M Sell
3,912
-137
-3% -$65.5K 0.03% 321
2025
Q1
$1.7M Buy
4,049
+146
+4% +$63.4K 0.02% 393
2024
Q4
$1.61M Sell
3,903
-2,120
-35% -$930K 0.02% 338
2024
Q3
$3.04M Sell
6,023
-103
-2% -$50K 0.04% 260
2024
Q2
$2.98M Sell
6,126
-162
-3% -$81.3K 0.04% 262
2024
Q1
$3.39M Sell
6,288
-216
-3% -$118K 0.05% 258
2023
Q4
$3.61M Buy
+6,504
New +$3.05M 0.05% 241
2021
Q3
Sell
-437
Closed -$276K 331
2021
Q2
$276K Buy
+437
New +$241K 0.02% 317
2019
Q1
Sell
-87
Closed -$16K 369
2018
Q4
$16K Buy
+87
New +$17.8K 0.01% 236

Other funds holding IDXX

Prime Capital Investment Advisors's IDXX Position: Q2 2026 in Review

Prime Capital Investment Advisors increased its Idexx Laboratories (IDXX) stake by 1.2% in Q2 2026, buying an estimated $26.4K and bringing the position to 3,952 shares worth $2.08M. The position accounts for 0.02% of the portfolio, ranked #374.

Prime Capital Investment Advisors first reported a position in IDXX in Q4 2018 and has held it in 13 quarters since. The position peaked at $3.61M in Q4 2023. 936 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Prime Capital Investment Advisors held 3,952 shares of Idexx Laboratories worth $2.08M as of Q2 2026.
  • Prime Capital Investment Advisors bought 47 Idexx Laboratories shares in Q2 2026, an estimated $26.4K.
  • Idexx Laboratories made up 0.02% of Prime Capital Investment Advisors's portfolio in Q2 2026, its #374 holding.
  • Prime Capital Investment Advisors first reported a position in Idexx Laboratories in Q4 2018 and has held it in 13 quarters since.
  • Prime Capital Investment Advisors's Idexx Laboratories position peaked at $3.61M in Q4 2023.
  • 936 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Prime Capital Investment Advisors's 13F filing for Q2 2026, filed 5 Aug 2026.